Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant small » significantly smaller (Expand Search), significant spatial (Expand Search), significant overall (Expand Search)
decrease based » disease based (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant small » significantly smaller (Expand Search), significant spatial (Expand Search), significant overall (Expand Search)
decrease based » disease based (Expand Search)
-
141
-
142
-
143
-
144
The Throttle Effect in Metal–Organic Frameworks for Distinguishing Water Isotopes
Published 2024Subjects: -
145
The Throttle Effect in Metal–Organic Frameworks for Distinguishing Water Isotopes
Published 2024Subjects: -
146
-
147
-
148
-
149
-
150
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C...
Published 2022“…Inspired by the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …”
-
151
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C...
Published 2022“…Inspired by the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …”
-
152
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung C...
Published 2022“…Inspired by the synergistic antitumor effect between NAD(P)H:quinone oxidoreductase 1 (NQO1) substrates increasing the NAD consumption and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors hampering the NAD synthesis, first-in-class small molecules simultaneously targeting NQO1 and NAMPT were identified through structure-based design. …”
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160